Use of ketogenic dietary therapy for drug-resistant epilepsy in early infancy.

Marisa ArmenoSilvana CalligarisDaniela GagiuloAraceli CrestaMaria Magdalena VaccarezzaCecilia Griselda DiezMaria Julia AlbertiRocio ViollazFrancisco VilavedraRoberto H Caraballo

Published in: Epilepsia open (2023)

Our experience suggests that KDT is safe and effective in newborns and very young infants; however, further studies on the management of the diet in this vulnerable age group are necessary.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
pregnant women
physical activity
weight loss
case control
middle aged
gestational age
low birth weight
cord blood
preterm infants
cystic fibrosis